Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients
Abstract
The COVID-19 pandemic has focused interest on the renin-angiotensin system (RAS), as it is not only part of its infection process but also of the lung injury, a major cause of its morbidity and mortality. The current state of our understanding of RAS has led to conflicting suggestions regarding how RAS and its role in COVID-19 should inform treating COVID-19. It has been suggested that angiotensin-converting enzyme (ACE) inhibitors or...
Paper Details
Title
Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients
Published Date
Jul 1, 2020
Journal
Volume
38
Issue
7
Pages
1386 - 1386
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History